Luminas, Editha B.
HRN: 24-98-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2024
CEFUROXIME 1.5GM (VIAL)
05/10/2024
05/17/2024
IV
1.5
Q8
Thalamic Hemorrhage
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes